Skip to content

A prospective trial of esomeprazole effect on the healing process of post-gastric endscopic submucosal dissection (ESD) ulcers

A prospective trial of esomeprazole effect on the healing process of post-gastric endscopic submucosal dissection (ESD) ulcers - efficacy of esomeprazole for post-ESD ulcers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000009367
Enrollment
100
Registered
2013-11-20
Start date
2013-11-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer, gastric adenoma

Interventions

None listed

Sponsors

Tsuchiura kyodo hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who will undergo ESD for gastric neoplasms at Tsuchiura kyodo hospital

Exclusion criteria

Exclusion criteria: 1)Patients who are pregnant or nursing 2)Drug allergy for esomeprazole 3)Patients who are diagnosed as unsuitable for this trial by investigator

Design outcomes

Primary

MeasureTime frame
the healing rates of post-ESD ulcers at 4, 8 weeks after ESD

Secondary

MeasureTime frame
the rate of post-ESD bleeding with emergent endoscopy

Countries

Japan

Contacts

Public ContactTakashi Ichida

Tsuchiura kyodo hospital Division of gastroenterology

taka_taka_0621@yahoo.co.jp029-823-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026